Every record from Nordanalyt · page 4
The slowest and most precise contributor. The only lab here offering ion-pair, SEC and ICP-MS as routine. Measured offset against the reference laboratory is -0.005 pp on 357 paired lots. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-043056 | Semax | KP | KP-2509-J5482 | 2026-Q1 | 99.91 | 9.36 | 100.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043160 | Retatrutide | SSA | SSA-2601-T7702 | 2026-Q1 | 99.04 | 5.37 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042879 | MK-677 (Ibutamoren mesylate) | GGPeps | GGPE-2509-T2530 | 2026-Q1 | 99.61 | 4.26 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-041471 | Humanin (HNG) | QYB | QYB-2512-A5720 | 2026-Q1 | 99.47 | 4.06 | 97.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043304 | L-Glutathione (reduced) | CPC | CPC-2602-D2535 | 2026-Q1 | 98.12 | 7.51 | — | Supplier-supplied | 0 | FAIL |
| AX-2026-041313 | ARA-290 | WWB | WWB-2511-S3009 | 2026-Q1 | 99.93 | 4.81 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041552 | TB-500 | QYB | QYB-2511-H6699 | 2026-Q1 | 99.14 | 6.71 | 105.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-043553 | MK-677 (Ibutamoren mesylate) | BCH | BCH-2601-G7069 | 2026-Q1 | 98.01 | 3.91 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-043378 | Gonadorelin | CPC | CPC-2508-B3242 | 2026-Q1 | 98.54 | 5.11 | — | Supplier-supplied | 3 | MARGINAL |
| AX-2026-041580 | CJC-1295 with DAC | QSC | QSC-2512-G6894 | 2026-Q1 | 98.85 | 2.69 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043426 | CJC-1295 (no DAC) | WXT | WXT-2601-P4636 | 2026-Q1 | 98.07 | 6.80 | 93.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042045 | Tirzepatide | TFC | TFC-2508-L6746 | 2026-Q1 | 98.04 | 1.92 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041929 | Retatrutide | TFC | TFC-2508-V4179 | 2026-Q1 | 98.16 | 3.98 | 89.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042511 | Semax | ERP | ERP-2512-G6974 | 2026-Q1 | 99.71 | 8.61 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041556 | TB-500 | QYB | QYB-2511-H6699 | 2026-Q1 | 99.70 | 6.58 | 94.0 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041494 | TB-500 | QYB | QYB-2512-R5934 | 2026-Q1 | 99.93 | 3.74 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042830 | BPC-157 | GGPeps | GGPE-2512-N1746 | 2026-Q1 | 99.43 | 6.65 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042426 | BPC-157 | SWB | SWB-2601-D5672 | 2026-Q1 | 99.82 | 3.65 | 95.3 | Supplier-supplied | 0 | PASS |
| AX-2026-041253 | Semaglutide | WWB | WWB-2602-X2511 | 2026-Q1 | 98.87 | 5.33 | — | Supplier-supplied | 0 | PASS |
| AX-2026-041349 | CJC-1295 with DAC | WWB | WWB-2508-V3100 | 2026-Q1 | 99.93 | 6.67 | — | Supplier-supplied | 0 | PASS |
| AX-2026-043061 | Semax | KP | KP-2509-J5482 | 2026-Q1 | 99.93 | 10.02 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042978 | Retatrutide | KP | KP-2511-K4263 | 2026-Q1 | 97.67 | 3.30 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041722 | BPC-157 | QSC | QSC-2510-J9685 | 2026-Q1 | 99.93 | 5.09 | 95.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-041421 | GHRP-2 | WWB | WWB-2511-K4194 | 2026-Q1 | 99.87 | 4.54 | 91.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-043580 | Tirzepatide | BCH | BCH-2602-V8155 | 2026-Q1 | 98.00 | 6.24 | — | Buyer-sourced | 2 | MARGINAL |
| AX-2026-041550 | TB-500 | QYB | QYB-2511-H6699 | 2026-Q1 | 99.67 | 6.16 | 104.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042606 | Semax | GGPeps | GGPE-2511-X8435 | 2026-Q1 | 98.63 | 7.38 | 107.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042840 | CJC-1295 with DAC | GGPeps | GGPE-2510-T1661 | 2026-Q1 | 98.45 | 6.19 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041985 | Semaglutide | TFC | TFC-2602-H5189 | 2026-Q1 | 98.85 | 1.67 | 96.0 | Laboratory-retained | 1 | MARGINAL |
| AX-2026-041612 | CJC-1295 (no DAC) | QSC | QSC-2508-D7983 | 2026-Q1 | 99.18 | 2.60 | 91.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042144 | Leuprolide | Homopeptide | HOMO-2508-N8842 | 2026-Q1 | 99.69 | 4.77 | 96.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042680 | Retatrutide | GGPeps | GGPE-2510-R9180 | 2026-Q1 | 99.80 | 2.96 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042015 | 5-Amino-1MQ | TFC | TFC-2508-L6321 | 2026-Q1 | 99.24 | 5.73 | 96.3 | Buyer-sourced | 2 | FAIL |
| AX-2026-043496 | Leuprolide | WXT | WXT-2511-S5991 | 2026-Q1 | 97.47 | 5.56 | — | Laboratory-retained | 1 | FAIL |
| AX-2026-042491 | Melanotan II | SWB | SWB-2602-J6019 | 2026-Q1 | 99.89 | 4.65 | 95.9 | Supplier-supplied | 1 | MARGINAL |
| AX-2026-042371 | CJC-1295 with DAC | SWB | SWB-2510-N4367 | 2026-Q1 | 97.74 | 2.66 | 95.2 | Supplier-supplied | 2 | MARGINAL |
| AX-2026-041506 | Enclomiphene citrate | QYB | QYB-2603-A6476 | 2026-Q1 | 99.33 | 4.53 | — | Supplier-supplied | 1 | FAIL |
| AX-2026-043567 | Tirzepatide | BCH | BCH-2601-N7656 | 2026-Q1 | 97.22 | 3.76 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2026-042222 | PT-141 (Bremelanotide) | Homopeptide | HOMO-2512-V9618 | 2026-Q1 | 99.36 | 4.58 | 106.2 | Buyer-sourced | 0 | PASS |
| AX-2026-041495 | TB-500 | QYB | QYB-2512-R5934 | 2026-Q1 | 99.93 | 4.27 | — | Supplier-supplied | 0 | PASS |